Țară: Spania
Limbă: engleză
Sursă: HMA (Heads of Medicines Agencies)
flunixin meglumine 50 mg/ml
COOPHAVET
QM01AG90
Solution for injection
flunixin
Cattle, Horses, Pigs
2013-01-23
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Wellicox 50 mg/ml solution for injection for cattle, pigs and horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE : Flunixin........................................................ 50 mg (as meglumine) EXCIPIENTS: Phenol ......................................................... 5 mg Sodium formaldehyde sulfoxylate .................. 2.5 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Colourless to pale yellow solution, clear and exempt of particles, with a slight odour of phenol. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, pigs and horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle: - Alleviation of clinical signs when respiratory disease concurrently with appropriate anti- infective therapy. Pigs: - To support appropriate antibiotic therapy in the treatment of Mastitis-Metritis-Agalactia syndrome. - Alleviation of fever associated with respiratory diseases as an adjunctive therapy to specific antibiotic therapy. Horses: - Alleviation of inflammation and pain associated with musculo-skeletal disorders. - Alleviation of visceral pain associated with colic. 4.3 CONTRAINDICATIONS Do not use in animals suffering from chronic musculo-skeletal disorders. Do not use in animals suffering from cardiac, hepatic or renal disease. Do not use in animals with gastro-intestinal lesions (gastro-intestinal ulceration or bleeding). 3 Do not use in case of hemorrhagi Citiți documentul complet